Sun Pharma Advanced Research Company has reported result for the fourth quarter and year ended March 31, 2015.
The company has reported a net loss of Rs 9.40 crore for the quarter ended March 31, 2015 as compared to a net loss of Rs 2.51 crore for the same quarter in the previous year. Total income of the company decreased by 4.60% at Rs 43.13 crore for quarter under review as compared to Rs 45.21 crore for the quarter ended March 31, 2014.
For the year ended March 31, 2015, the company has posted a net loss of Rs 39.52 crore as compared to a net profit of Rs 30.32 crore for the same period in the previous year. Total income of the company has decreased by 10.31% at Rs 158.77 crore for year under review as compared to Rs 177.03 crore for the period ended March 31, 2014.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 436.10 |
| Indegene | 528.50 |
| CMS Info Systems | 301.35 |
| JITF Infralogistics | 319.75 |
| Sagility | 40.02 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: